SteelPeak Wealth LLC Sells 14,514 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

SteelPeak Wealth LLC decreased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 32.4% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 30,343 shares of the medical equipment provider's stock after selling 14,514 shares during the period. SteelPeak Wealth LLC's holdings in Intuitive Surgical were worth $15,028,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of ISRG. Vanguard Group Inc. grew its stake in Intuitive Surgical by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider's stock worth $16,813,478,000 after buying an additional 360,591 shares during the last quarter. Geode Capital Management LLC grew its stake in Intuitive Surgical by 3.2% during the fourth quarter. Geode Capital Management LLC now owns 7,756,727 shares of the medical equipment provider's stock worth $4,039,200,000 after buying an additional 243,802 shares during the last quarter. Norges Bank bought a new stake in Intuitive Surgical during the fourth quarter worth about $2,401,493,000. Invesco Ltd. grew its stake in Intuitive Surgical by 7.7% during the fourth quarter. Invesco Ltd. now owns 4,148,180 shares of the medical equipment provider's stock worth $2,165,184,000 after buying an additional 295,025 shares during the last quarter. Finally, Northern Trust Corp grew its stake in Intuitive Surgical by 15.8% during the fourth quarter. Northern Trust Corp now owns 3,619,293 shares of the medical equipment provider's stock worth $1,889,126,000 after buying an additional 494,496 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock traded down $13.99 during trading hours on Friday, reaching $512.06. The company's stock had a trading volume of 2,951,229 shares, compared to its average volume of 1,679,961. Intuitive Surgical, Inc. has a one year low of $413.82 and a one year high of $616.00. The company has a market capitalization of $183.53 billion, a P/E ratio of 75.08, a P/E/G ratio of 5.58 and a beta of 1.64. The stock's fifty day simple moving average is $537.85 and its two-hundred day simple moving average is $536.69.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. The firm had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same period last year, the firm earned $1.50 earnings per share. As a group, research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Activity

In related news, EVP Gary Loeb sold 1,700 shares of the firm's stock in a transaction dated Friday, April 25th. The shares were sold at an average price of $513.18, for a total transaction of $872,406.00. Following the completion of the sale, the executive vice president owned 2,245 shares in the company, valued at approximately $1,152,089.10. This trade represents a 43.09% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Jami K. Nachtsheim sold 2,400 shares of the firm's stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the sale, the director owned 6,371 shares of the company's stock, valued at $3,312,920. This trade represents a 27.36% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 4,998 shares of company stock worth $2,611,577. Corporate insiders own 0.70% of the company's stock.

Analysts Set New Price Targets

ISRG has been the topic of several research analyst reports. Truist Financial decreased their price objective on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a research note on Wednesday, April 23rd. Piper Sandler decreased their price target on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 23rd. Robert W. Baird decreased their price target on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 23rd. Citigroup reissued a "buy" rating and set a $650.00 price target (up from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Finally, BTIG Research set a $560.00 price target on shares of Intuitive Surgical and gave the company a "buy" rating in a research note on Monday, April 14th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $592.59.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.